Pharmaceuticals

October 26, 2026
MK615 Apricot Extract: Lab Promise vs. Limited Human Trial Data
While viral clips claim MK615 kills 95% of cancer cells, a small Phase I trial showed only disease stabilization, not tumor shrinkage,…
October 18, 2026
Viatris Secures FDA Approval for RYZUMVI to Treat Presbyopia in Adults
Viatris wins FDA approval for RYZUMVI to treat presbyopia, adding a new option for aging eyes while seeking a U.S. commercial partner.
October 16, 2026
FDA Approves First Drug for Deadly Rare Brain Disease: A Game-Changer for Patients
Madison, October 16 — The US Food and Drug Administration has approved Zanvastro, the first drug designed to directly treat Alexander disease,…
October 6, 2026
Manufacturing Site Issues Delay FDA Decision on Novo’s Once-Monthly Hemophilia A Drug Denecimig
Bagsværd, October 6 — Novo Nordisk confirmed on October 2 that the FDA review of its denecimig biologics license application remains delayed…
October 2, 2026
FDA October 2026 Decision Calendar Light Following September Rare Disease Approvals
WASHINGTON, October 2 — The FDA’s October 2026 decision calendar is relatively light compared to previous months, with a limited number of…
July 17, 2026
Trethera Scientist Dr. Gary J. Peltz Leads dCK Inhibitor Development
LOS ANGELES, July 17 — On the seventh floor of a biotechnology office building here, Dr. Gary J. Peltz is closing in…
July 14, 2026
New Alzheimer’s Drug Lecanemab Slows Cognitive Decline in Trial
WASHINGTON, July 14 — For the millions of American families watching a loved one slowly lose their memories, the arrival of lecanemab…
July 11, 2026
$40B Global Antibiotics Industry Faces Innovation Gaps
SINGAPORE, July 11 — For communities across Asia, the medicines that treat common infections are something many families take for granted. But…
July 10, 2026
CAR-T Therapy Reprograms Patients’ Immune Cells to Fight Cancer
ISLAMABAD, July 10 — For patients and families facing blood cancers, the word “remission” carries a weight that is both fragile and…
July 8, 2026
Senolytics: Clearing Senescent Cells to Combat Age-Related Disease
ROCHESTER, Minnesota, July 8 — For a field that began with a single question about aging cells, senolytic research has come a…
June 30, 2026
Philippine Doctors Sound Alarm Over Prescription Drug Sales on Quick-Commerce Apps
MANILA — The doctor on the phone asked Ratish Sharma how old he was and how long he had been taking Telma…
June 9, 2026
Roche Launches Subcutaneous Lung Cancer Immunotherapy in India
MUMBAI — The needle goes in. Seven minutes later, it’s over. That is the new reality for lung cancer patients in India,…
July 17, 2025
Breakthrough Narcolepsy Treatment Shows Promise in Phase 3 Trials Recently
For many years, treatment for narcolepsy has centered on alleviating symptoms rather than correcting the disorder’s root cause. Takeda’s experimental compound, oveporexton,…
May 21, 2025
Eli Lilly Mazdutide Weight Loss Drug Shows Promise
China, May 21, 2025 — infopulsetoday.com — New clinical data released in May 2025 show that the investigational drug mazdutide, a once-weekly…
February 4, 2025
Vertex’s New Painkiller Targets Nerves Without Opioid Risks
Vertex Pharmaceuticals is awaiting a regulatory decision on suzetrigine, a non-opioid analgesic designed for moderate to severe acute pain. The drug, which…
February 3, 2025
Novo Nordisk maintains global leadership in diabetes and obesity care innovation
On February 3, 2025, Novo Nordisk A/S, a Danish multinational pharmaceutical company, continued to make its mark in the health industry as…
October 11, 2024
GLP-1 Hormone Holds Promise for Diabetes and Obesity Treatment Advances
A hormone first characterized in the 1980s has become the foundation of a major transformation in how physicians manage diabetes and obesity.…
April 21, 2024
US Faces Unprecedented 2024 Drug Shortage Crisis Nationwide
The scope of the 2024 drug shortage in the United States extends far beyond a simple inventory problem, now affecting over 300…
March 12, 2024
Migraine Drug Class Elevated to Standard Treatment
America, March 12, 2024 — cyberinktimes.com — For millions of Americans who live with migraines, the standard advice has long been the…
December 15, 2023
Rimegepant Approved for Migraine Treatment in Multiple Countries
Rimegepant, sold under the brand name Nurtec ODT, has expanded its presence as a treatment and prevention option for adult migraines across…
November 18, 2023
FDA Approves New Lung Cancer Drug Augtyro Despite Significant Side Effects
The U.S. Food and Drug Administration granted approval on November 15, 2023, for Repotrectinib, marketed as Augtyro, to treat a defined group…
August 16, 2023
New Cancer Drug Forces Immune Cells to Attack Myeloma
On August 15, 2023, regulators in the United States and the European Union granted approval to talquetamab, a therapeutic that enlists the…
August 16, 2023
New Drug Forces Immune Cells to Attack Multiple Myeloma
August 15, 2023, brought a significant shift for multiple myeloma patients who had exhausted existing therapies. On that date, regulatory authorities in…
December 20, 2022
Nadofaragene firadenovec approved for bladder cancer treatment
United States, December 20, 2022 — cybernewschronicle.com — Nadofaragene firadenovec, a gene therapy marketed under the brand name Adstiladrin, has been approved…